Stage 2 Stocks in Medical Devices
35 US stocks in Medical Devices are in Stage 2, the advancing phase of Weinstein's stage analysis. Listed below: those priced at $5 or more and trading at least $1 million a day on average, ranked by setup score and updated after every close (last close Oct 23, 2026).
| Stock | Close | 1D | Setup | Weeks in stage |
|---|---|---|---|---|
| RCEL Avita Medical, Inc. | $15.51 | +0.58% | 7.9 | 13 |
| SIBN SI-BONE, Inc. | $21.48 | -0.37% | 7.8 | 13 |
| HAE Haemonetics Corporation | $118.51 | +2.02% | 7.8 | 18 |
| CBLL CeriBell, Inc. | $27.13 | -0.99% | 7.4 | 11 |
| INFU InfuSystems Holdings, Inc. | $13.94 | -1.41% | 7.4 | 12 |
| MASS 908 Devices Inc. | $11.49 | +1.23% | 7.2 | 24 |
| BVS Bioventus Inc. Class A | $14.96 | -0.53% | 7.0 | 16 |
| GKOS Glaukos Corporation | $178.88 | +1.24% | 6.9 | 25 |
| ITGR Integer Holdings Corporation | $126.54 | -0.02% | 6.5 | 21 |
| SGHT Sight Sciences, Inc. | $8.99 | -1.10% | 6.4 | 10 |
| UFPT UFP Technologies, Inc. | $295.78 | -0.52% | 6.2 | 17 |
| CTKB Cytek Biosciences, Inc. | $5.59 | +2.95% | 6.2 | 6 |
| MDT Medtronic plc. | $95.41 | -1.22% | 6.2 | 6 |
| VREX Varex Imaging Corporation | $18.42 | +0.05% | 5.8 | 10 |
| KIDS OrthoPediatrics Corp. | $24.50 | -0.85% | 5.6 | 17 |
| CNMD CONMED Corporation | $49.25 | -0.38% | 5.2 | 10 |
| NEOG Neogen Corporation | $12.19 | +1.75% | 4.9 | 14 |
| BIO Bio-Rad Laboratories, Inc. Class A | $369.95 | +1.77% | 4.8 | 13 |
| TXG 10x Genomics, Inc. | $71.55 | +2.58% | 4.7 | 48 |
| SENS Senseonics Holdings, Inc. | $7.51 | +1.49% | 4.6 | 8 |
| DCTH Delcath Systems, Inc. | $14.42 | -2.24% | 4.4 | 23 |
| DXCM DexCom, Inc. | $77.94 | -0.49% | 4.4 | 17 |
| BRKR Bruker Corporation | $57.59 | +0.49% | 3.9 | 21 |
| BFLY Butterfly Network, Inc. Class A | $6.76 | -0.73% | 3.8 | 27 |
| INSP Inspire Medical Systems, Inc. | $71.11 | -2.13% | 3.8 | 4 |
| BBNX Beta Bionics, Inc. | $19.16 | -0.93% | 3.5 | 8 |
Medical Devices: quick answers
Which stocks in Medical Devices are in an uptrend?
As of Oct 23, 2026, 35 US stocks in Medical Devices are in Stage 2, the uptrend phase. The largest by market value are Medtronic, DexCom, Glaukos, Bio-Rad Laboratories and 10x Genomics.
How many stocks in Medical Devices are in Stage 2?
35 of the 141 stocks we track in Medical Devices (24.8%) are in Stage 2. 9 are basing in Stage 1, 15 are topping in Stage 3 and 78 are in a Stage 4 downtrend. That share has fallen 3.5 points over the last 20 sessions.
Which stocks in Medical Devices entered Stage 2 recently?
1 stock entered Stage 2 in the last four weeks: Inspire Medical Systems (week 4).
Daily screens
Every one recalculated after the close, with the exact criteria published on the page.
Stage 2 in other sectors & industries
US stocks in a confirmed uptrend (Stage 2, Weinstein’s advancing phase), grouped by sector and industry and ranked by setup score.